Search Login Register

Cyclophosphamide (Cytoxan) Summary

Description: Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer.

Also Known As: Cytoxan; Neosar; B-518; Cyclophosphamide Monohydrate; Cyclophosphamide, (+-)-Isomer Show All >>

Networked: 18416 relevant articles (2124 outcomes, 3178 trials/studies) for this Drug

Key Diseases for which Cyclophosphamide is Relevant

  1. Neoplasms (Cancer) : 233 outcomes 445 studies in 3060 results
  2. Breast Neoplasms (Breast Cancer) : 212 outcomes 796 studies in 2245 results
  3. Lymphoma (Lymphomas) : 87 outcomes 99 studies in 690 results
  4. Lupus Nephritis : 82 outcomes 93 studies in 424 results
  5. Non-Hodgkin Lymphoma (Lymphosarcoma) : 74 outcomes 150 studies in 617 results
Show All >>

Drugs Related to Cyclophosphamide

  1. Doxorubicin (Adriamycin)
  2. Vincristine (Oncovin)
  3. Prednisone (Sone)
  4. rituximab (Mabthera)
  5. Methotrexate (Mexate)
  6. Prednisolone (Predate)
  7. Fluorouracil (Carac)
  8. Etoposide (VP 16)
  9. Cisplatin (Platino)
  10. Adrenal Cortex Hormones (Corticosteroids)
Show All >>

Therapies Related to Cyclophosphamide

  1. Drug Therapy (Chemotherapy)
  2. Combination Drug Therapy (Combination Chemotherapy)
  3. Bone Marrow Transplantation (Transplantation, Bone Marrow)
  4. Transplants (Transplant)
  5. Adjuvant Chemotherapy
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.